Assertio Holdings Inc (ASRT)
1.00
-0.01
(-0.99%)
USD |
NASDAQ |
May 15, 14:14
Assertio Holdings Cash from Financing (Quarterly): -0.206M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.206M |
| December 31, 2023 | -8.915M |
| September 30, 2023 | -0.01M |
| June 30, 2023 | -16.33M |
| March 31, 2023 | -18.95M |
| December 31, 2022 | -0.798M |
| September 30, 2022 | 2.888M |
| June 30, 2022 | -7.441M |
| March 31, 2022 | -2.443M |
| December 31, 2021 | -7.522M |
| September 30, 2021 | -0.356M |
| June 30, 2021 | -7.569M |
| March 31, 2021 | 44.47M |
| December 31, 2020 | -7.969M |
| September 30, 2020 | -10.23M |
| June 30, 2020 | -90.24M |
| March 31, 2020 | -360.11M |
| December 31, 2019 | -19.97M |
| September 30, 2019 | -54.29M |
| June 30, 2019 | -55.14M |
| March 31, 2019 | -28.44M |
| December 31, 2018 | -25.20M |
| September 30, 2018 | 0.114M |
| June 30, 2018 | -56.63M |
| March 31, 2018 | 0.36M |
| Date | Value |
|---|---|
| December 31, 2017 | -12.53M |
| September 30, 2017 | -0.093M |
| June 30, 2017 | -99.94M |
| March 31, 2017 | 1.684M |
| December 31, 2016 | -0.652M |
| September 30, 2016 | 1.282M |
| June 30, 2016 | -101.93M |
| March 31, 2016 | 1.123M |
| December 31, 2015 | -5.706M |
| September 30, 2015 | 3.32M |
| June 30, 2015 | 566.07M |
| March 31, 2015 | 4.413M |
| December 31, 2014 | 3.40M |
| September 30, 2014 | 336.75M |
| June 30, 2014 | 3.948M |
| March 31, 2014 | 3.118M |
| December 31, 2013 | 241.62M |
| September 30, 2013 | 1.18M |
| June 30, 2013 | 0.668M |
| March 31, 2013 | 0.408M |
| December 31, 2012 | 0.801M |
| September 30, 2012 | 0.444M |
| June 30, 2012 | 0.973M |
| March 31, 2012 | 0.468M |
| December 31, 2011 | 0.425M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-360.11M
Minimum
Mar 2020
44.47M
Maximum
Mar 2021
-31.06M
Average
-7.769M
Median
Cash from Financing (Quarterly) Benchmarks
| Ocular Therapeutix Inc | 321.22M |
| Vertex Pharmaceuticals Inc | -357.50M |
| Cormedix Inc | -0.0971M |
| Verastem Inc | 0.846M |
| CytomX Therapeutics Inc | 0.174M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 7.508M |
| Free Cash Flow | 34.40M |
| Free Cash Flow Per Share (Quarterly) | 0.079 |
| Free Cash Flow to Equity (Quarterly) | 7.401M |
| Free Cash Flow to Firm (Quarterly) | 8.288M |
| Free Cash Flow Yield | 40.26% |